Fibre is fermented by gut bacteria into short-chain fatty acids, which activate other receptors (FFAR2 and FFAR3) that also trigger GLP-1 release
6 For someone starting semaglutide specifically for weight management, B420's metabolic endpoint evidence is relevant to the same goals driving the medication choice
Sleep When you sleep, your body releases growth hormone along with other hormones
Animal-longevity results vary by species, strain and statistical endpoint
Furthermore, this treatment inertia is partly due to the absence of clear guidelines on how to reduce insulin doses when adding alternative glucose-lowering therapies, making it more likely that insulin therapy will continue uninterrupted
After 3 months of semaglutide, the percentage of patients with EE decreased from 72.5 to 11.5%, the percentage of patients with external eating decreased from 27.5 to 10.1%, the percentage of patients with craving decreased from 49.3 to 21.7%, and the percentage of patients with savory craving decreased from 53.6 to 14.5% [59]